GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced the launch of its Herpes Zoster vaccine, Shingrix ...
Researchers conducted an observational study to compare the risk for dementia associated with both the live and recombinant shingles vaccines.
RZV is an approved shingles vaccine to combine a non-live antigen with GSK's adjuvant and may help overcome the natural age-related decline in immunity that contributes to the challenge of ...
Co-administration of the RSV and shingles adjuvanted vaccines was well tolerated, with acceptable reactogenicity and safety ...
The latest research suggests that the recombinant shingles vaccine may offer additional benefits. It appears to reduce the ...
PHN is characterised by pain lasting from three months to several years after the rash subsides, and it is also the most ...
Follow today’s news live. Biden caught on hot mic telling Albanese and other Quad leaders China 'testing us' 04:43 ...
Dr Alap said GSK is pleased that people in Malaysia will now have access to the RZV vaccine to help reduce the burden of shingles disease. “RZV is an approved non-live adjuvanted shingles vaccine and ...